Maximizing depression treatments with behavioural therapy
Cognitive behavioural therapy enhances effects of anti-depressant drugs in Malaysia
SELANGOR, Malaysia, Sep 20, 2017 - (ACN Newswire) - Augmenting conventional, pharmaceutical-based treatment of depression with cognitive behavioural therapy reduces depressive symptoms of Malaysians more over a shorter period of time than other treatment methods, according to a study in the journal Social Sciences and Humanities.
| The research suggests that Malaysian health officials should consider providing cognitive behavioural therapy (CBT) in a group setting as a supplement to drug-centred therapy. (Copyright: Cathy Yeulet via 123rf) |
Cognitive behavioural therapy (CBT) is a form of "talk therapy" designed to give patients the skills to identify and interrupt patterns of negative thinking and reflexive behaviours that may contribute to mental health problems.
A team of researchers from Universiti Putra Malaysia, Universiti Kebangsaan Malaysia, and the University of Queensland in Australia analysed the effect of CBT on Malaysians. They found that patients treated with CBT along with medication showed greater improvement in a shorter amount of time than other treatment groups.
The research suggests that Malaysian health officials should consider providing CBT in a group setting as a supplement to drug-centred therapy. This would help maximize potential benefits in the face of limited mental healthcare budgets. "Our findings have important implications for how depression is treated in Malaysia," said lead researcher Low Jia Liang. "It's possible that using CBT in conjunction with pharmacotherapy could bring about significant improvements more quickly, and thereby maximize the impact of constrained health care resources."
As in the rest of the world, depression is a major health concern in Malaysia. The World Health Organization estimates 350 million people suffer from the mood disorder. Within Malaysia, the Institute of Public Health reports that 2.3 million people are at risk for depression within their lifetimes, while other research pegs the incidence of depression in parts of the country as high as 10.3 percent.
Numerous international studies have indicated that CBT can provide effective treatment for depression. However, almost all of those studies have been conducted in Western countries. That raises concerns that cultural differences -- for example, the difference between the "individualistic" nature of Western societies versus the "collectivist" outlook in Asia -- may make CBT less effective for Asian patients.
To design a robust study for Malaysia, the researchers made sure participants reflected the diverse ethnic composition of the country. Participants were divided into three groups: a third received CBT and treatment with anti-depressants; another third were treated solely with anti-depressants; and the final cohort received "relaxation therapy," where they learned physical and mental relaxation techniques, alongside anti-depressants.
Patients in the group treated with CBT along with medication fared better than the other two groups. "What this tells us," said Low Jia Liang, "is that the conventional wisdom about the effectiveness of CBT holds true in the Malaysian context."
For more information on this research, contact: Low Jia Liang Universiti Putra Malaysia Email: joel.law85@gmail.com The original paper is available at: http://bit.ly/2fiIqZZ
About Pertanika Journal of Social Sciences & Humanities (JSSH) Pertanika Journal of Social Sciences & Humanities (JSSH) is published by Universiti Putra Malaysia in English and is open to authors around the world regardless of nationality. It is published four times a year in March, June, September and December. Other Pertanika series include Pertanika Journal of Tropical Agricultural Science (JTAS), and Pertanika Journal of Science & Technology (JST).
JSSH aims to develop as a pioneer journal for the social sciences with a focus on emerging issues pertaining to the social and behavioural sciences as well as the humanities. Areas relevant to the scope of the journal include Social Sciences -- Accounting, anthropology, Archaeology and history, Architecture and habitat, Consumer and family economics, Economics, Education, Finance, Geography, Law, Management studies, Media and communication studies, Political sciences and public policy, Population studies, Psychology, Sociology, Technology management, Tourism; Humanities -- Arts and culture, Dance, Historical and civilisation studies, Language and Linguistics, Literature, Music, Philosophy, Religious studies, Sports.
The journal publishes original academic articles dealing with research on issues of worldwide relevance. The journals cater for scientists, professors, researchers, post-docs, scholars and students who wish to promote and communicate advances in the fields of Social Sciences & Humanities research. www.pertanika.upm.edu.my
For more information about the journal, contact: The Chief Executive Editor (UPM Journals) Head, Journal Division, UPM Press Office of the Deputy Vice Chancellor (R&I) IDEA Tower 2, UPM-MDTC Technology Centre Universiti Putra Malaysia, Selangor, Malaysia Phone: +603 8947 1622, Email: nayan@upm.my
Distributed for Pertanika Journal of Science & Technology by ResearchSEA.
Source: Pertanika Journal Sectors: Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe Apr 19, 2024 13:50 JST
| Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces Apr 19, 2024 10:17 JST
| Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas Apr 18, 2024 17:01 JST
| Toyota Launches All-New Land Cruiser "250" Series in Japan Apr 18, 2024 13:39 JST
| Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan Apr 18, 2024 11:14 JST
| Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category) Apr 18, 2024 10:53 JST
| All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating Apr 18, 2024 09:22 JST
| Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan Apr 17, 2024 16:17 JST
| Honda Unveils Next-generation EV Series for China Apr 17, 2024 12:15 JST
| Lexus presents Time at the 2024 Milan Design Week Apr 16, 2024 18:49 JST
| Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA Apr 16, 2024 14:36 JST
| New circuit challenge for TOYOTA GAZOO Racing Apr 15, 2024 17:21 JST
| TOYOTA GAZOO Racing back on asphalt for Croatian challenge Apr 12, 2024 19:36 JST
| Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project Apr 12, 2024 14:39 JST
| MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors Apr 11, 2024 18:08 JST
| Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS) Apr 11, 2024 17:50 JST
| DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission Apr 11, 2024 15:10 JST
| Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp Apr 11, 2024 13:07 JST
| Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine Apr 10, 2024 16:55 JST
| Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 Apr 10, 2024 13:36 JST
|
More Latest Release >>
|